{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1361699996301072640.json","@type":"Article","productIdentifier":[{"identifier":{"@type":"DOI","@value":"10.1002/1097-0142(20000601)88:11<2505::aid-cncr11>3.0.co;2-e"}},{"identifier":{"@type":"URI","@value":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(20000601)88:11%3C2505::AID-CNCR11%3E3.0.CO;2-E"}},{"identifier":{"@type":"URI","@value":"https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(20000601)88:11%3C2505::AID-CNCR11%3E3.0.CO;2-E"}}],"dc:title":[{"@value":"A phase II trial of biweekly high dose gemcitabine for patients with metastatic pancreatic adenocarcinoma"}],"creator":[{"@id":"https://cir.nii.ac.jp/crid/1381699996301072649","@type":"Researcher","foaf:name":[{"@value":"Herbert Ulrich-Pur"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072648","@type":"Researcher","foaf:name":[{"@value":"Gabriela V. Kornek"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072650","@type":"Researcher","foaf:name":[{"@value":"Markus Raderer"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072644","@type":"Researcher","foaf:name":[{"@value":"Karin Haider"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072645","@type":"Researcher","foaf:name":[{"@value":"Werner Kwasny"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072641","@type":"Researcher","foaf:name":[{"@value":"Dieter Depisch"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072643","@type":"Researcher","foaf:name":[{"@value":"Renate Greul"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072647","@type":"Researcher","foaf:name":[{"@value":"Bruno Schneeweiss"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072642","@type":"Researcher","foaf:name":[{"@value":"Gwendolyn Krauss"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072640","@type":"Researcher","foaf:name":[{"@value":"Josef Funovics"}]},{"@id":"https://cir.nii.ac.jp/crid/1381699996301072646","@type":"Researcher","foaf:name":[{"@value":"Werner Scheithauer"}]}],"publication":{"publicationIdentifier":[{"@type":"PISSN","@value":"0008543X"},{"@type":"EISSN","@value":"10970142"}],"prism:publicationName":[{"@value":"Cancer"}],"dc:publisher":[{"@value":"Wiley"}],"prism:publicationDate":"2000-06-01","prism:volume":"88","prism:number":"11","prism:startingPage":"2505","prism:endingPage":"2511"},"reviewed":"false","dc:rights":["http://doi.wiley.com/10.1002/tdm_license_1.1"],"url":[{"@id":"https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(20000601)88:11%3C2505::AID-CNCR11%3E3.0.CO;2-E"},{"@id":"https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(20000601)88:11%3C2505::AID-CNCR11%3E3.0.CO;2-E"}],"createdAt":"2002-08-25","modifiedAt":"2021-07-01","relatedProduct":[{"@id":"https://cir.nii.ac.jp/crid/1390282680165338752","@type":"Article","relationType":["isReferencedBy"],"jpcoar:relatedTitle":[{"@language":"en","@value":"Advanced Pancreatic Cancer Successfully Treated with Biweekly Low-Dose Gemcitabine"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1002/1097-0142(20000601)88:11<2505::aid-cncr11>3.0.co;2-e"},{"@type":"CROSSREF","@value":"10.4993/acrt.16.21_references_DOI_DjZWT6b6qGllDPtEMblv27mMMSX"}]}